Related references
Note: Only part of the references are listed.MiR-132, miR-15a and miR-16 synergistically inhibit pituitary tumor cell proliferation, invasion and migration by targeting Sox5
Wang Renjie et al.
CANCER LETTERS (2015)
Direct intracerebral delivery of a miR-33 antisense oligonucelotide into mouse brain increases brain ABCA1 expression
Asad Jan et al.
NEUROSCIENCE LETTERS (2015)
Fetal Alcohol Exposure Reduces Dopamine Receptor D2 and Increases Pituitary Weight and Prolactin Production via Epigenetic Mechanisms
Omkaram Gangisetty et al.
PLOS ONE (2015)
Fetal Alcohol Exposure Alters Proopiomelanocortin Gene Expression and Hypothalamic-Pituitary-Adrenal Axis Function via Increasing MeCP2 Expression in the Hypothalamus
Omkaram Gangisetty et al.
PLOS ONE (2014)
Each Individual Isoform of the Dopamine D2 Receptor Protects from Lactotroph Hyperplasia
Daniela Radl et al.
MOLECULAR ENDOCRINOLOGY (2013)
MicroRNA-200c Inhibits Apoptosis in Pituitary Adenoma Cells by Targeting the PTEN/Akt Signaling Pathway
Chuangxin Liao et al.
ONCOLOGY RESEARCH (2013)
Estrogen inhibits D2S receptor-regulated Gi3 and Gs protein interactions to stimulate prolactin production and cell proliferation in lactotropic cells
A. Sengupta et al.
JOURNAL OF ENDOCRINOLOGY (2012)
Regulatory Roles of Heterogeneous Nuclear Ribonucleoprotein M and Nova-1 Protein in Alternative Splicing of Dopamine D2 Receptor Pre-mRNA
Eonyoung Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Polypyrimidine tract-binding protein 1 regulates the alternative splicing of dopamine receptor D-2
Toshikazu Sasabe et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Dopamine agonist-resistant prolactinomas
Michael C. Oh et al.
JOURNAL OF NEUROSURGERY (2011)
Differential expression of microRNAs in GH-secreting pituitary adenomas
Zhi-Gang Mao et al.
DIAGNOSTIC PATHOLOGY (2010)
Expression of D2RmRNA isoforms and ERmRNA isoforms in prolactinomas: correlation with the response to bromocriptine and with tumor biological behavior
Zhe Bao Wu et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Ethanol exposure induces differential microRNA and target gene expression and teratogenic effects which can be suppressed by folic acid supplementation
Lin-Lin Wang et al.
HUMAN REPRODUCTION (2009)
MicroRNAs Differentially Expressed in ACTH-Secreting Pituitary Tumors
Fernando Colbari Amaral et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas
Arianna Bottoni et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Advances in the treatment of prolactinomas
Mary P. Gillam et al.
ENDOCRINE REVIEWS (2006)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Ethanol and estradiol modulate alternative splicing of dopamine D2 receptor messenger RNA and abolish the inhibitory action of bromocriptine on prolactin release from the pituitary gland
S Oomizu et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2003)
Control of lactotrop proliferation by dopamine: Essential role of signaling through D2 receptors and ERKs
C Iaccarino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms
KG Schuff et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Dopamine as a prolactin (PRL) inhibitor
N Ben-Jonathan et al.
ENDOCRINE REVIEWS (2001)